GGrantIndex
Sort

40,608 grants matching prostate cancer

Biology and vulnerabilities of POU2F3+ tuft cell-like carcinomas

$673,208
Christopher Vakoc · Cold Spring Harbor Laboratory · R01 · FY2025 · CA

A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate Cancer

$673,092
Renata Pasqualini · Rbhs -Cancer Institute Of New Jersey · R01 · FY2018 · CA

San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR)

$673,050
Ian M Thompson · University Of Texas Hlth Science Center · U01 · FY2014 · CA

Harnessing the nervous system to overcome resistance to immunotherapy in oral cancer

$673,034
Moran Amit · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · DE

Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction

$672,998
Leonard Neckers · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA

PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER

$672,912
University Of Alabama At Birmingham · N01 · FY2000 · CN

Early Diagnosis of Pancreatic Cancer

$672,897
Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2007 · CA

Orally active CBP/p300 degraders

$672,792
Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2025 · CA

Enhancing the Efficacy of Docetaxel in Prostate Cancer

$672,762
Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA

BETA CATENIN IN PROSTATE CANCER APOPTOSIS

$672,750
Loyola University Of Chicago · · FY2010 · Department of the Army

Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV

$672,541
Corinne E. Joshu · Johns Hopkins University · R01 · FY2024 · CA

Uncovering causal protein markers to improve prostate cancer etiology understanding and risk prediction in Africans and Europeans

$672,541
Lang Wu · University Of Hawaii At Manoa · R01 · FY2025 · CA

Career Development in Pediatric and Medical Oncology

$672,442
Irwin Bernstein · Fred Hutchinson Cancer Research Center · K12 · FY2018 · CA

Impact of Web-Based Lifestyle Interventions on Prostate Cancer Prognosis

$672,441
Stacey Kenfield · University Of California, San Francisco · R01 · FY2017 · CA

Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer

$672,298
Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA

Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer

$672,298
Johannes F Fahrmann · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA

A transdisciplinary approach for dissecting stem cell states in prostate cancer

$672,295
Raul Rabadan · Columbia University Health Sciences · U01 · FY2021 · CA

CHEMISTRY AND BIOLOGY OF PLATINUM ANTICANCER DRUGS

$672,247
Stephen J Lippard · Massachusetts Institute Of Technology · R37 · FY2008 · CA

Dual kV/MV Imaging for Metal Artifact Reduction

$672,218
Rebecca Fahrig · Stanford University · R01 · FY2012 · CA

Use of silver nanostructures on microtransponders in ultra-sensitive assay

$672,201
Wlodek Mandecki · Pharmaseq, Inc. · R44 · FY2010 · CA

Data Processing, Analysis and Modeling Unit

$672,104
Jeremy Goecks · Oregon Health & Science University · U2C · FY2020 · CA

Angiotensin II Receptors And Signaling Mechanisms

$672,058
Kevin J Catt · Child Health And Human Development · Z01 · FY2007 · HD

Impact of Web-Based Lifestyle Interventions on Prostate Cancer Prognosis

$672,016
Stacey Kenfield · University Of California, San Francisco · R01 · FY2018 · CA

Optimizing Lung Cancer Screening in Cancer Survivors

$671,950
Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA

Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II)

$671,948
Paul A. Godley · Univ Of North Carolina Chapel Hill · U54 · FY2013 · CA